跳至主要内容
临床试验/NCT05700409
NCT05700409已完成不适用

Evaluating a Telemedicine-based Intensive Treatment Program for Children and Adolescents With Obesity

Sheba Medical Center2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2023年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
2
主要终点
Weight status

研究概览

简要总结

The study objective is to evaluate whether a novel telemedicine-based intensive treatment program for children with obesity is superior to standard on-site care. This will be a randomized, non-blinded (due to the nature of the intervention) study, where 100 children and adolescents aged 10-18 years with obesity will be divided in a 1:1 ratio to either telemedicine or on-site treatments for 6 months.

The telemedicine arm will include 30, mostly video, consultations for each participant: 3 physician appointments, 7 exercise consultations by our exercise physiologist, 10 dietary consultations by our pediatric dietitian, and 10 psychologist consultations to assist with goal setting and overall well-being. Three visits will be conducted in-office, for physician assessment, smartphone technical assistance and physical measurements (baseline, at 3 months and at the end of the 6-month period). Participants randomized to the telemedicine arm will have a step-counting rewarding app installed on their smartphone by our staff.

The in-office arm will have 6 monthly visits during the study period, with two consultations performed in each visit - one by the physician or exercise physiologist, and one by our pediatric dietitian.

The main outcome of the study is BMI standard deviation (z-score) changes, which will be evaluated after 3 and 6 months of treatment during physical office visits in both study arms.

Secondary outcomes will be:

  • Body-fat percent changes, assessed by bioimpedance analysis in physical clinic visits.
  • Daily step counts, measured by smartphone data/ wearable activity tracker, if available.
  • Weight-related quality of life
  • Retention and visit cancellation rates.
  • Satisfaction of both parent and child from their allocated treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
10 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Obesity, defined as a BMI at or above 2 standard deviations SDs according to the WHO growth reference
  • Owning a smartphone, needed for video conversations, step counting and the gamification app
  • Parent consent and child's assent to participate in the program

排除标准

  • Significant physical or mental barriers to physical activity and/or to dietary changes (such as autistic spectrum disorder that precludes dietary changes or sufficient exercise, as assessed by the PI)

研究组 & 干预措施

Telemedicine

Experimental

The telemedicine arm will include 30, mostly video, consultations for each participant: 3 physician appointments, 7 exercise consultations by our exercise physiologist, 10 dietary consultations by our pediatric dietitian, and 10 psychologist consultations to assist with goal setting and overall well-being. Three visits will be conducted in-office, for physician assessment, smartphone technical assistance and physical measurements (baseline, at 3 months and at the end of the 6-month period). Participants randomized to the telemedicine arm will have a step-counting rewarding app installed on their smartphone by our staff.

干预措施: Intensive lifestyle consultations (Behavioral)

On-site

Active Comparator

The on-site arm will have 6 monthly visits during the study period, with two consultations performed in each visit - one by the physician or exercise physiologist, and one by our pediatric dietitian.

干预措施: Intensive lifestyle consultations (Behavioral)

结局指标

主要结局

Weight status

时间窗: From baseline to 6 months

BMI z-score change

次要结局

  • Daily step counts(At 6 months)
  • Body-fat percent changes(From baseline to 6 months)
  • Weight-related quality of life(6 months)
  • Visit cancellation rates(6 months)
  • Retention in program(6 months)
  • Satisfaction of allocated treatment(6 months)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Gal Raz-Dubnov MD, MSc

Director, Pediatric LIfestyle Clinic

Sheba Medical Center

研究点 (2)

Loading locations...

相似试验